{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Lee. Patient is 71yo female. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed malignant neoplasm on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 82 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: Lingula, LUL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in Lingula. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Johnson. Patient is 62yo male. We targeted the RUL and RLL using Ion and Cios Spin. Both nodules showed malignant neoplasm on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 62-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n62-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Patel. Patient is 71yo female. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed malignant neoplasm on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 74 M. Targets: RML, RUL. rEBUS Eccentric/Eccentric. ROSE: suspicious for malignancy. Fiducial in RML. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 88 M\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RUL, RLL\nFindings: suspicious for malignancy (ROSE)\nIntervention: Fiducial placed in RUL. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 71 M. Targets: Lingula, LUL. rEBUS Eccentric/Eccentric. ROSE: atypical cells present. Fiducial in Lingula. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 74 M. Targets: RUL, RLL. rEBUS Eccentric/Eccentric. ROSE: atypical cells present. Fiducial in RUL. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 82 F. Targets: Lingula, LUL. rEBUS Eccentric/Concentric. ROSE: malignant neoplasm. Fiducial in Lingula. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 65 M. Targets: RML, RUL. rEBUS Concentric/Concentric. ROSE: suspicious for malignancy. Fiducial in RML. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 74 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: Lingula, LUL\nFindings: malignant neoplasm (ROSE)\nIntervention: Fiducial placed in Lingula. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "71 M bilat nodules RUL RLL. ion/rebus/cios used. suspicious for malignancy. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 88 F. Targets: RML (1.5 cm), RUL (1.2 cm). Path: atypical cells present.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "88 F bilat nodules LUL LLL. ion/rebus/cios used. atypical cells present. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Rodriguez. Patient is 88yo male. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed suspicious for malignancy on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Johnson. Patient is 62yo male. We targeted the Lingula and LUL using Ion and Cios Spin. Both nodules showed atypical cells present on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 62-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n62-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 91 M\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RML, RUL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in RML. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 91-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n91-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "71 F bilat nodules LUL LLL. ion/rebus/cios used. atypical cells present. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "82 F bilat nodules LUL LLL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 74 M\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RUL, RLL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in RUL. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 82 F. Targets: RUL (1.8 cm), RLL (1.5 cm). Path: malignant neoplasm.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 82 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RML, RUL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in RML. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 88 M. Targets: LUL (2.1 cm), LLL (0.8 cm). Path: diagnostic for carcinoma.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 79 F. Targets: Lingula (1.8 cm), LUL (1.0 cm). Path: atypical cells present.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Johnson. Patient is 88yo female. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed suspicious for malignancy on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Johnson. Patient is 82yo male. We targeted the RUL and RLL using Ion and Cios Spin. Both nodules showed malignant neoplasm on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 91 F. Targets: RML (1.2 cm), RUL (2.1 cm). Path: suspicious for malignancy.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 91-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n91-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 71 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: LUL, LLL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in LUL. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 82 M. Targets: RML (2.1 cm), RUL (1.8 cm). Path: suspicious for malignancy.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 71 F. Targets: RUL (2.1 cm), RLL (2.1 cm). Path: atypical cells present.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 82 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RUL, RLL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in RUL. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "74 F bilat nodules RUL RLL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 79 F. Targets: RUL (1.8 cm), RLL (1.0 cm). Path: malignant neoplasm.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Smith. Patient is 65yo male. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed diagnostic for carcinoma on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "91 M bilat nodules RUL RLL. ion/rebus/cios used. malignant neoplasm. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 91-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n91-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "91 F bilat nodules Lingula LUL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 91-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n91-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 88 F. Targets: Lingula (1.2 cm), LUL (1.8 cm). Path: atypical cells present.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 82 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: Lingula, LUL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in Lingula. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 65 M\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: Lingula, LUL\nFindings: suspicious for malignancy (ROSE)\nIntervention: Fiducial placed in Lingula. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 82 F. Targets: LUL, LLL. rEBUS Concentric/Concentric. ROSE: atypical cells present. Fiducial in LUL. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "88 M bilat nodules Lingula LUL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 88 F. Targets: LUL (0.8 cm), LLL (1.5 cm). Path: atypical cells present.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 62 F. Targets: RUL (1.8 cm), RLL (1.0 cm). Path: suspicious for malignancy.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 62-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n62-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 82 F. Targets: RML (1.2 cm), RUL (1.2 cm). Path: malignant neoplasm.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Rodriguez. Patient is 71yo female. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed suspicious for malignancy on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 82 M\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RML, RUL\nFindings: malignant neoplasm (ROSE)\nIntervention: Fiducial placed in RML. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "79 M bilat nodules LUL LLL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 65 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RML, RUL\nFindings: malignant neoplasm (ROSE)\nIntervention: Fiducial placed in RML. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 71 F. Targets: RML (1.5 cm), RUL (2.1 cm). Path: diagnostic for carcinoma.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Johnson. Patient is 62yo male. We targeted the RUL and RLL using Ion and Cios Spin. Both nodules showed atypical cells present on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 62-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n62-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 79 F. Targets: Lingula (2.1 cm), LUL (0.8 cm). Path: diagnostic for carcinoma.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Smith. Patient is 82yo female. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed diagnostic for carcinoma on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Smith. Patient is 74yo female. We targeted the RML and RUL using Ion and Cios Spin. Both nodules showed diagnostic for carcinoma on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 79 M. Targets: LUL, LLL. rEBUS Concentric/Concentric. ROSE: malignant neoplasm. Fiducial in LUL. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Lee. Patient is 74yo female. We targeted the Lingula and LUL using Ion and Cios Spin. Both nodules showed malignant neoplasm on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "82 F bilat nodules Lingula LUL. ion/rebus/cios used. malignant neoplasm. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 82 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: Lingula, LUL\nFindings: diagnostic for carcinoma (ROSE)\nIntervention: Fiducial placed in Lingula. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 71 M. Targets: RML, RUL. rEBUS Eccentric/Eccentric. ROSE: malignant neoplasm. Fiducial in RML. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 65 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RML, RUL\nFindings: atypical cells present (ROSE)\nIntervention: Fiducial placed in RML. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 91 F. Targets: RUL, RLL. rEBUS Eccentric/Eccentric. ROSE: malignant neoplasm. Fiducial in RUL. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 91-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Lee\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n91-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "74 F bilat nodules LUL LLL. ion/rebus/cios used. malignant neoplasm. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 88 F\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: RML, RUL\nFindings: suspicious for malignancy (ROSE)\nIntervention: Fiducial placed in RML. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 74 F. Targets: RUL, RLL. rEBUS Eccentric/Concentric. ROSE: suspicious for malignancy. Fiducial in RUL. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 79 F. Targets: RML (0.8 cm), RUL (1.5 cm). Path: diagnostic for carcinoma.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 91 F. Targets: Lingula (1.2 cm), LUL (2.1 cm). Path: diagnostic for carcinoma.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 91-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n91-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Patel. Patient is 88yo female. We targeted the RUL and RLL using Ion and Cios Spin. Both nodules showed suspicious for malignancy on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Smith. Patient is 88yo male. We targeted the RUL and RLL using Ion and Cios Spin. Both nodules showed atypical cells present on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "82 F bilat nodules LUL LLL. ion/rebus/cios used. suspicious for malignancy. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "65 F bilat nodules Lingula LUL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 79 F. Targets: Lingula, LUL. rEBUS Concentric/Eccentric. ROSE: suspicious for malignancy. Fiducial in Lingula. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Patel. Patient is 71yo male. We targeted the LUL and LLL using Ion and Cios Spin. Both nodules showed suspicious for malignancy on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 79 F. Targets: RUL, RLL. rEBUS Concentric/Concentric. ROSE: diagnostic for carcinoma. Fiducial in RUL. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for RUL and RLL Superior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RUL and RLL Superior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RUL and RLL Superior targets \nTransbronchial cryobiopsy of RUL target \nTransbronchial biopsy (forceps) and brushing of RUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Gomez\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apical Segment of RUL (RB1).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RLL Superior Nodule Robotic navigation was performed to the Superior Segment of RLL (RB6).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RLL Superior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRUL nodule: BAL \u2014 Microbiology.\nRLL Superior nodule: TBNA (6 samples) \u2014 Cytology.\nRLL Superior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRUL Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nRLL Superior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Patient: 74 M\nProcedure: Ion Robotic Bronchoscopy + EBUS\nTargets: LUL, LLL\nFindings: malignant neoplasm (ROSE)\nIntervention: Fiducial placed in LUL. EBUS staging negative.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 74-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n74-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 82 F. Targets: LUL, LLL. rEBUS Concentric/Eccentric. ROSE: atypical cells present. Fiducial in LUL. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 82-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for LUL and LLL nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to LUL and LLL targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of LUL and LLL targets \nTransbronchial cryobiopsy of LUL target \nTransbronchial biopsy (forceps) and brushing of LUL target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (LUL) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: LUL Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Apico-posterior Segment of LUL (LB1+2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LLL Nodule Robotic navigation was performed to the Lateral Basal Segment of LLL (LB9).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LLL to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 11Ri.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLUL nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLUL nodule: BAL \u2014 Microbiology.\nLLL nodule: TBNA (6 samples) \u2014 Cytology.\nLLL nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n82-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLUL Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nLLL Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "79 M bilat nodules RML RUL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 79-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n79-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 65 F. Targets: RML, RUL. rEBUS Eccentric/Concentric. ROSE: atypical cells present. Fiducial in RML. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nAtypical cells present (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Johnson\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.5 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of atypical cells present.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of atypical cells present.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for atypical cells present.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for atypical cells present.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Gen Anesth Robotic Bronch. Pt 65 M. Targets: RML, RUL. rEBUS Eccentric/Concentric. ROSE: malignant neoplasm. Fiducial in RML. EBUS staging neg.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 65-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nMalignant neoplasm (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.2 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of malignant neoplasm.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 2.1 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of malignant neoplasm.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n65-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for malignant neoplasm.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for malignant neoplasm.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "91 M bilat nodules Lingula LUL. ion/rebus/cios used. diagnostic for carcinoma. fiducial placed t1. ebus staging clear. no comps.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 91-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nDiagnostic for carcinoma (ROSE confirmation for Lingula and LUL Anterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to Lingula and LUL Anterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of Lingula and LUL Anterior targets \nTransbronchial cryobiopsy of Lingula target \nTransbronchial biopsy (forceps) and brushing of Lingula target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (Lingula) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Patel\nASSISTANT Dr. Wright\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: Lingula Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Superior Segment of the Lingula (LB4).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: LUL Anterior Nodule Robotic navigation was performed to the Anterior Segment of LUL (LB3).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: 1.1mm cryoprobe used; 3 samples collected successfully.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of diagnostic for carcinoma.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the LUL Anterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nLingula nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nLingula nodule: BAL \u2014 Microbiology.\nLUL Anterior nodule: TBNA (6 samples) \u2014 Cytology.\nLUL Anterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n91-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nLingula Nodule: ROSE conclusive for diagnostic for carcinoma.\nFiducial marker placed.\n\nLUL Anterior Nodule: ROSE conclusive for diagnostic for carcinoma.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Procedures: Robotic Nav Bronch (Ion), Radial EBUS, Cone Beam CT, Fiducial Placement. Dx: R91.1. Pt: 71 M. Targets: RML (0.8 cm), RUL (1.0 cm). Path: suspicious for malignancy.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 71-year-old male who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Smith\nASSISTANT Dr. Kim\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 0.8 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 11Rs, 11L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n71-year-old male with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
{"prompt": "Record a robotic bronchoscopy note for Dr. Dr. Rodriguez. Patient is 88yo female. We targeted the RML and RUL using Ion and Cios Spin. Both nodules showed suspicious for malignancy on ROSE. EBUS was performed, no nodes sampled.", "completion": "NOTE_ID: note_058\nSOURCE_FILE: note_058.txt\n\nINTERVENTIONAL PULMONOLOGY OPERATIVE REPORT\n\nDATE OF PROCEDURE: [Date] CC Referred Physician: [Name / Self, Referred]\n\nINDICATION FOR OPERATION 88-year-old female who presents with lung nodules requiring bronchoscopic diagnosis.\nThe nature, purpose, risks, benefits, and alternatives to Bronchoscopy were discussed with the patient in detail.\nThe patient wished to proceed and informed consent was signed.\n\nCONSENT Obtained before the procedure.\nIndications, potential complications, and alternatives were discussed with the patient or surrogate.\nConsent was signed and witnessed by an assisting medical professional.\n\nPREOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \n\nPOSTOPERATIVE DIAGNOSIS\nR91.1 Solitary Lung Nodule \nSuspicious for malignancy (ROSE confirmation for RML and RUL Posterior nodules) \n\nPROCEDURE\nRobotic navigational bronchoscopy (Ion) to RML and RUL Posterior targets \nRadial EBUS (rEBUS) localization \nCone-beam CT imaging (Cios Spin) with trajectory adjustment and confirmation \nTBNA of RML and RUL Posterior targets \nTransbronchial cryobiopsy of RML target \nTransbronchial biopsy (forceps) and brushing of RML target \nBronchoalveolar lavage (BAL) \nFiducial marker placement (RML) \nEBUS mediastinal/hilar lymph node survey (inspection only) \n\nATTENDING Dr. Rodriguez\nASSISTANT Dr. Davis\nSUPPORT STAFF RN: [Name] RT: [Name]\n\nANESTHESIA General Anesthesia \n\nMONITORING Pulse oximetry, heart rate, telemetry, and blood pressure were continuously monitored by an \nindependent trained observer throughout the procedure.\n\nINSTRUMENTATION Flexible Therapeutic Bronchoscope; Linear EBUS; Radial EBUS; Ion Robotic Bronchoscope; Cios Spin System.\nESTIMATED BLOOD LOSS None \n\nCOMPLICATIONS None \n\nPROCEDURE IN DETAIL After successful induction of anesthesia, a timeout was performed confirming patient identity, planned procedures, and procedure location.\nPatient position: [Supine]. Initial airway inspection: Successful therapeutic aspiration was performed to clean out the Right Mainstem, Bronchus Intermedius, and Left Mainstem from mucus.\nA CT-based navigation plan was loaded into the robotic bronchoscopy platform.\n\nTarget 1: RML Nodule Robotic navigation bronchoscopy was performed with the Ion platform using partial registration.\nThe Ion robotic catheter was used to engage the Medial Segment of RML (RB5).\nTarget: Lesion is approximately 1.0 cm in diameter. Catheter advanced to 1.0 cm from target under navigational guidance.\nrEBUS: Radial EBUS confirmed an Eccentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): A low-dose spin was performed. 3D reconstructions on an independent workstation were interpreted by the attending.\nAdjustment: The system was updated with the acquired nodule location and the robotic catheter was adjusted to the new target.\n\nSampling:\nTBNA: 21G needle; 4 samples collected.\nTransbronchial Biopsy: Alligator forceps; 1 sample collected.\nCryobiopsy: 1.1mm cryoprobe, 6-second freeze time; 6 samples collected.\nBrushing: Protected cytology brush; 1 sample collected.\nBAL: 20 cc NS instilled, 10 cc returned.\nFiducial: One 0.8mm x 3mm soft tissue gold marker was placed under fluoroscopy guidance.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nNo bleeding was noted prior to withdrawal.\n\nTarget 2: RUL Posterior Nodule Robotic navigation was performed to the Posterior Segment of RUL (RB2).\nTarget: Lesion is approximately 1.8 cm in diameter. Catheter advanced to 1.0 cm from target.\nrEBUS: Radial EBUS confirmed an Concentric signal. Features noted: Continuous margin and absence of linear-discrete air bronchogram.\nCone-beam CT (Cios Spin): Spin performed, 3D images interpreted, and catheter position adjusted/confirmed.\n\nSampling:\nTBNA: 21G needle; 6 samples collected.\nCryobiopsy: Attempted but technically challenging; unable to penetrate airway wall for consistent biopsy.\nBAL: 60 cc NS instilled, 15 cc returned.\n\nROSE: Conclusive evidence of suspicious for malignancy.\nHemostasis: 200mg of Tranexamic Acid (TXA) was placed in the RUL Posterior to achieve hemostasis. No evidence of bleeding upon inspection.\n\nEBUS STAGING The EBUS bronchoscope was introduced. All lymph node stations were assessed.\nTechnique: Only nodes \u22655 mm in short axis were considered for sampling.\nEBUS elastography was performed to assess tissue stiffness (Type 1-3).\n\nStations Inspected: 4R, 4L, 7, 10R, 10L.\nSite 1 - Station 4L: <10 mm on CT, Non-Hypermetabolic on PET. Elastography Type 1 (soft/benign).\nNot sampled (not clinically indicated).\n\nSite 2 - Station 7: <10 mm on CT, Non-Hypermetabolic on PET.\nElastography Type 1 (soft/benign). Not sampled (not clinically indicated).\n\nOther Stations: No detectable lymph nodes noted in other stations.\nNo immediate complications. The patient was extubated in the operating room and transported to recovery in stable condition.\n\nSPECIMENS\nRML nodule: TBNA (4 samples), TBBX (1 sample), Cryobiopsy (6 samples), Brush (1 sample) \u2014 Pathology/Cytology.\nRML nodule: BAL \u2014 Microbiology.\nRUL Posterior nodule: TBNA (6 samples) \u2014 Cytology.\nRUL Posterior nodule: BAL \u2014 Cell Count, Microbiology, Cytology.\n\nIMPRESSION / PLAN\n88-year-old female with bilateral lung nodules successfully sampled via Robotic Bronchoscopy.\n\nRML Nodule: ROSE conclusive for suspicious for malignancy.\nFiducial marker placed.\n\nRUL Posterior Nodule: ROSE conclusive for suspicious for malignancy.\n\nEBUS Staging: Complete inspection performed;\nno nodes met criteria for sampling (benign elastography/size/PET features).\n\nFollow-up in clinic for final pathology results.\n"}
